Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

February 1, 2015

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Interventions
PROCEDURE

Transarterial Chemoembolization

A contrast agent (Xenetix350, Guerbet, France) was applied under local anaesthesia via the common femoral artery using a 5F sheath. Selective catheterization of the coeliac trunk and other arteries supplying the liver was then performed under fluoroscopic control. A pathological vascularization pattern was identified and chemoembolization material consisting of DC beads (BTG International Ltd) was injected by the treating angiographist using micro instrumentation. Follow-up CT or MRI was performed after 1-3 TACE sessions according to the extent of the lesion, 3 weeks following the last procedure. Patients with completed treatments were scheduled for an imaging follow-up every 3 months, allowing evaluation of the effect of treatment. In case of a positive response to the treatment another session of TACE was indicated. Chemoembolization sessions were performed as inpatient procedures with the mean hospitalization time of 4 days.

All Listed Sponsors
collaborator

Masaryk Memorial Cancer Institute

OTHER

collaborator

Masaryk University

OTHER

lead

Brno University Hospital

OTHER

NCT04780789 - Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization | Biotech Hunter | Biotech Hunter